We are live on ! Find out more
AGA

Altrinsic Global Advisors Portfolio holdings

AUM $2.79B
1-Year Est. Return 7.25%
This Fund
S&P 500
This Quarter Est. Return
-10.13%
1 Year Est. Return
+7.25%
3 Year Est. Return
+44.27%
5 Year Est. Return
+55.25%
10 Year Est. Return
+173.46%
AUM
$2.09B
AUM Growth
-$122M
Cap. Flow
+$156M
Cap. Flow %
7.48%
Top 10 Hldgs %
56.09%
Holding
89
New
5
Increased
44
Reduced
14
Closed
7

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$51.4M
2
IBN icon
ICICI Bank
IBN
+$23M
3
GE icon
GE Aerospace
GE
+$21.4M
4
AAP icon
Advance Auto Parts
AAP
+$13.4M
5
SABR icon
Sabre
SABR
+$11.5M

Sector Composition

Rank Sector Weight
1 Financials 31.76%
2 Communication Services 19.37%
3 Healthcare 12.93%
4 Technology 10.35%
5 Consumer Staples 7.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PRQR icon
51
ProQR Therapeutics
PRQR
$244M
$2.86M 0.14%
181,360
-10,000
-5% -$184K
BKD icon
52
Brookdale Senior Living
BKD
$3.55B
$2.7M 0.13%
402,452
VIV icon
53
Telefônica Brasil
VIV
$20.4B
$2.53M 0.12%
212,255
AKCA
54
DELISTED
Akcea Therapeutics Inc
AKCA
$2.27M 0.11%
75,286
-20,000
-21% -$561K
NUVA
55
DELISTED
NuVasive, Inc.
NUVA
$1.98M 0.1%
40,000
TS icon
56
Tenaris
TS
$28.2B
$1.89M 0.09%
88,494
+27,005
+44% +$749K
L icon
57
Loews
L
$24.5B
$1.81M 0.09%
39,802
VYGR icon
58
Voyager Therapeutics
VYGR
$181M
$1.78M 0.09%
189,927
+10,000
+6% +$128K
AAC
59
DELISTED
AAC Holdings
AAC
$1.64M 0.08%
1,174,370
+150,000
+15% +$602K
EHC icon
60
Encompass Health
EHC
$11.3B
$1.57M 0.08%
32,004
-3,438
-10% -$196K
NBIS
61
Nebius Group N.V.
NBIS
$37.6B
$1.49M 0.07%
54,528
-929
-2% -$27.3K
KURA icon
62
Kura Oncology
KURA
$793M
$1.47M 0.07%
105,000
+25,000
+31% +$331K
ARA
63
DELISTED
American Renal Associates Holdings, Inc
ARA
$1.38M 0.07%
120,000
+20,000
+20% +$341K
NVRO
64
DELISTED
NEVRO CORP.
NVRO
$1.36M 0.07%
+35,000
New +$1.56M
CSCO icon
65
Cisco
CSCO
$443B
$1.11M 0.05%
25,660
SHG icon
66
Shinhan Financial Group
SHG
$32.1B
$1.09M 0.05%
30,669
+19,036
+164% +$719K
XENE icon
67
Xenon Pharmaceuticals
XENE
$6.1B
$947K 0.05%
150,000
+30,000
+25% +$267K
FATE icon
68
Fate Therapeutics
FATE
$275M
$898K 0.04%
70,000
DVCR
69
DELISTED
Diversicare Healthcare Services Inc
DVCR
$886K 0.04%
373,952
NTES icon
70
NetEase
NTES
$83B
$863K 0.04%
18,335
+6,375
+53% +$288K
FPRX
71
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$837K 0.04%
90,000
ELGX
72
DELISTED
Endologix Inc
ELGX
$813K 0.04%
113,500
VIPS icon
73
Vipshop
VIPS
$7.26B
$686K 0.03%
125,615
ZTO icon
74
ZTO Express
ZTO
$18.2B
$682K 0.03%
43,093
SURF
75
DELISTED
Surface Oncology, Inc. Common Stock
SURF
$679K 0.03%
160,078
+10,078
+7% +$77.8K

Similar funds

Altrinsic Global Advisors's Q4 2018 Portfolio in Review

As of Q4 2018, Altrinsic Global Advisors held 89 positions worth $2.09B, down 5.5% from $2.21B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Altrinsic Global Advisors deployed $156M of net new capital in Q4 2018, opening 5 new positions and adding to 44 existing holdings. Its largest new stake was Hartford Financial Services: 642,963 shares worth $28.6M.

By sector, the portfolio is most concentrated in Financials at 32% of assets, up from 28% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Medtronic, an estimated $51.4M trimmed.

  • Altrinsic Global Advisors's largest Q4 2018 buy was Hartford Financial Services: 642,963 shares worth $28.6M.
  • Altrinsic Global Advisors added most to Baidu in Q4 2018, an estimated $55.5M increase.
  • Altrinsic Global Advisors's biggest Q4 2018 reduction was Medtronic, cutting an estimated $51.4M.
  • Altrinsic Global Advisors fully exited GE Aerospace in Q4 2018, selling an estimated $21.4M.
  • Altrinsic Global Advisors's ten largest holdings make up 56% of its $2.09B portfolio in Q4 2018.
  • Altrinsic Global Advisors opened 5 new positions and closed 7 in Q4 2018.
  • Altrinsic Global Advisors's portfolio value fell 5.5% quarter-over-quarter to $2.09B.

Based on Altrinsic Global Advisors's 13F filing for Q4 2018, filed 14 Feb 2019.